AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20542081 — intervention group
Group type: COMPARATOR
Intervention: Meaningless action preparation
Number of subjects: 0
Study 18493141 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 199
Study 18493141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 15888511 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 microg)
Number of subjects: 15
Study 15888511 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (300 microg)
Number of subjects: 15
Study 15888511 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (15 mg)
Number of subjects: 15
Study 15888511 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (30 mg)
Number of subjects: 15
Study 15888511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 12559511 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta 1a (IFNb1a)
Number of subjects: 0
Study 12559511 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta 1b (IFNb1b)
Number of subjects: 0
Study 12559511 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta 1a (IFNb1a) in SPECTRIMS trial
Number of subjects: 0
Study 10463516 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) 500 mg/d
Number of subjects: 0
Study 10463516 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) 750 mg/d
Number of subjects: 0
Study 10463516 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (ZDV) monotherapy
Number of subjects: 0
Study 10463516 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy with ddI/ZDV
Number of subjects: 0
Study 10463516 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy with zalcitabine/ZDV
Number of subjects: 0
Study 9035703 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene gel applied once daily
Number of subjects: 0
Study 9035703 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene gel
Number of subjects: 0
Study 1751274 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine 2.5 micrograms kg‐1 min‐1
Number of subjects: 142
Study 1751274 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine 2.5 micrograms kg‐1 min‐1
Number of subjects: 142
Study 1751274 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine 2.5 micrograms kg‐1 min‐1 (in subgroup with CPB > 2h)
Number of subjects: 142
Study 7201839 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotoxine (2 mg, three times a day)
Number of subjects: 44
Study 7201839 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (0.8 g, three times a day)
Number of subjects: 44
Study 31389771 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified permuted-block randomization
Number of subjects: 0
Study 31389771 — intervention group
Group type: COMPARATOR
Intervention: Simple randomization
Number of subjects: 0
Study 29433493 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Individual Placement and Support (IPS) with pain treatment
Number of subjects: 0
Study 29433493 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 26651393 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine supplementation during pregnancy
Number of subjects: 49
Study 26651393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 23322312 — intervention group
Group type: EXPERIMENTAL
Intervention: Philip Morris 'QuitAssist' PSA
Number of subjects: 56
Study 23322312 — intervention group
Group type: EXPERIMENTAL
Intervention: Legacy 'truth' antismoking PSA
Number of subjects: 56
Study 23322312 — intervention group
Group type: COMPARATOR
Intervention: Control PSA
Number of subjects: 56
Study 22257126 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (n=157)
Number of subjects: 309
Study 22257126 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=152)
Number of subjects: 309
Study 20376490 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 120
Study 20376490 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (TM)
Number of subjects: 120
Study 18179325 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining being in a meaningful location for the final time
Number of subjects: 0
Study 18179325 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminded of the ending on graduation day
Number of subjects: 0
Study 15721840 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (lipopolysaccharide)
Number of subjects: 9
Study 15721840 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 9
Study 12872363 — intervention group
Group type: EXPERIMENTAL
Intervention: Iseganan
Number of subjects: 323
Study 12872363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study 10859864 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 ml PCECV intradermally at two sites on days 0, 3, 7, and at one site on days 30 and 90
Number of subjects: 211
Study 10859864 — intervention group
Group type: COMPARATOR
Intervention: Purified Vero cell rabies vaccine (PVRV) administered similarly to Group 1
Number of subjects: 211
Study 10859864 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 ml PCECV intramuscularly on days 0, 3, 7, 14, 30 and 90
Number of subjects: 211
Study 9174306 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiport epidural catheters
Number of subjects: 500
Study 9174306 — intervention group
Group type: COMPARATOR
Intervention: Uniport epidural catheters
Number of subjects: 500
Study 9174306 — intervention group
Group type: COMPARATOR
Intervention: Multiport and Uniport epidural catheters
Number of subjects: 500
Study 8517428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salt diet (20 mEq/day sodium)
Number of subjects: 9
Study 8517428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salt diet with enalapril
Number of subjects: 9
Study 8517428 — intervention group
Group type: COMPARATOR
Intervention: High salt diet (20 mEq/day sodium + eleven 1 g salt tablets per day)
Number of subjects: 9
Study 2872814 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg terazosin
Number of subjects: 12
Study 2872814 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg terazosin
Number of subjects: 12
Study 2872814 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg terazosin
Number of subjects: 12
Study 2872814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30685455 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous personal carbon monoxide (CO) exposure
Number of subjects: 840
Study 30685455 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-hand tobacco smoke exposure
Number of subjects: 840
Study 29713249 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 PUFA (capsules containing 180 mg of eicosapentaenoic acid and 120 mg of docosahexaenoic acid)
Number of subjects: 30
Study 29713249 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 PUFA
Number of subjects: 30
Study 29713249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (gelatin capsules)
Number of subjects: 30
Study 26959502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile screening and teleophthalmology for diabetic retinopathy and maculopathy assessment
Number of subjects: 0
Study 26959502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile screening and teleophthalmology for diabetic maculopathy assessment
Number of subjects: 0
Study 26959502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile unit laser photocoagulation treatment
Number of subjects: 0
Study 26959502 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to outpatient eye clinic for follow-up treatment
Number of subjects: 0
Study 26959502 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of visual acuity
Number of subjects: 0
Study 24865696 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 gI/kg
Number of subjects: 150
Study 24865696 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 gI/kg
Number of subjects: 150
Study 24865696 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 gI/kg
Number of subjects: 150
Study 24865696 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.28 gI/kg
Number of subjects: 150
Study 24865696 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.6 gI/m(2)
Number of subjects: 150
Study 22710865 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels before induction chemotherapy (day 0) in patient group 1 (children with acute leukemia)
Number of subjects: 44
Study 22710865 — intervention group
Group type: COMPARATOR
Intervention: Neopterin levels in control group 1 (children with infection)
Number of subjects: 44
Study 22710865 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels at day 15 of induction in patient group 1
Number of subjects: 44
Study 22710865 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels at day 33 of induction in patient group 1
Number of subjects: 44
Study 22710865 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels during neutropenic fever in patient group 2
Number of subjects: 44
Study 22710865 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels in patients with microbiologically and/or clinically documented infections vs those with fever of unknown origin in patient group 2
Number of subjects: 44
Study 22710865 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of serum neopterin with absolute neutrophil count and absolute monocyte count
Number of subjects: 44
Study 20075952 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin-alfa treatment to a target hemoglobin level of 13.5 g/dl
Number of subjects: 0
Study 20075952 — intervention group
Group type: COMPARATOR
Intervention: Target hemoglobin level of 11.3 g/dl
Number of subjects: 0
Study 17392660 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol septal ablation (ASA) - 1-3 ml of absolute alcohol introduced into the septal branch to create a controlled septal infarction.
Number of subjects: 0
Study 17392660 — intervention group
Group type: COMPARATOR
Intervention: Surgical myectomy
Number of subjects: 0
Study 15652878 — intervention group
Group type: EXPERIMENTAL
Intervention: Euthymic bipolar disorder patients (n=15)
Number of subjects: 15
Study 15652878 — intervention group
Group type: COMPARATOR
Intervention: First-degree relatives of bipolar probands (n=27)
Number of subjects: 15
Study 15652878 — intervention group
Group type: COMPARATOR
Intervention: Remitted patients with major depressive disorder (n=15)
Number of subjects: 15
Study 15652878 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (n=15 for experiment 1, n=46 for experiment 2)
Number of subjects: 15
Study 11966509 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron 4 mg b.d.
Number of subjects: 22
Study 11966509 — intervention group
Group type: COMPARATOR
Intervention: Placebo b.d.
Number of subjects: 22
Study 10803997 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 70
Study 10803997 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 70
Study 7611868 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen type IV concentration measurement in peritoneal fluid
Number of subjects: 49
Study 2292350 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg i.v.)
Number of subjects: 16
Study 2292350 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 16
Study 6786673 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25-0.5 microgram oral 1,25-dihydroxy vitamin D3
Number of subjects: 57
Study 6786673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 31072217 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening aerobic exercise (30 min at 75% HRmax)
Number of subjects: 12
Study 31072217 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening resistance exercise (30 min at 75% of 10-repetition maximum)
Number of subjects: 12
Study 31072217 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 12
Study 30219790 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy within 0-6 hours
Number of subjects: 830
Study 30219790 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy within 6-16 hours
Number of subjects: 830
Study 30219790 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy within 16-24 hours
Number of subjects: 830
Study 28049262 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (110 mg BTPP) of black tea drink
Number of subjects: 24
Study 28049262 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (220 mg BTPP) of black tea drink
Number of subjects: 24
Study 28049262 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (0 mg BTPP)
Number of subjects: 24
Study 25977992 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.125% + sufentanil 0.75 μg/mL
Number of subjects: 181
Study 25977992 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.2% + sufentanil 0.75 μg/mL
Number of subjects: 181
Study 25977992 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 181
Study 25004353 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely obese (BMI > 45)
Number of subjects: 585
Study 22796450 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy plus rectal insufflation of O(3)
Number of subjects: 53
Study 22796450 — intervention group
Group type: COMPARATOR
Intervention: Antithrombotic therapy only
Number of subjects: 53
Study 20075532 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 60
Study 20075532 — intervention group
Group type: COMPARATOR
Intervention: Conventional opioid based analgesia
Number of subjects: 60
Study 17353246 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin (8 g)
Number of subjects: 0
Study 17353246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15811655 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg of AMA1
Number of subjects: 29
Study 15811655 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg of AMA1
Number of subjects: 29
Study 15811655 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 microg of AMA1
Number of subjects: 29
Study 15811655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 15811655 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA1 (all doses)
Number of subjects: 29
Study 12007591 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (Olz)
Number of subjects: 1995
Study 12007591 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (Hal)
Number of subjects: 1995
Study 10463136 — intervention group
Group type: EXPERIMENTAL
Intervention: Propinox 20 mg
Number of subjects: 350
Study 10463136 — intervention group
Group type: EXPERIMENTAL
Intervention: Propinox 30 mg
Number of subjects: 350
Study 10463136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study 7789347 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers smoking (SS) during light activity
Number of subjects: 39
Study 7789347 — intervention group
Group type: COMPARATOR
Intervention: Smokers not smoking (SNS) during light activity
Number of subjects: 39
Study 7789347 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers (NS) during light activity
Number of subjects: 39
Study 7789347 — intervention group
Group type: COMPARATOR
Intervention: All groups at rest
Number of subjects: 39
Study 2407581 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of fasting insulin distribution
Number of subjects: 474
Study 2407581 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose
Number of subjects: 474
Study 2407581 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting insulin
Number of subjects: 474
Study 2407581 — intervention group
Group type: COMPARATOR
Intervention: BMI and centrality index
Number of subjects: 474
Study 7041031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A + Telecobalt irradiation
Number of subjects: 78
Study 7041031 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecobalt irradiation
Number of subjects: 78
Study 7041031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A + Cytoxan
Number of subjects: 78
Study 7041031 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic therapy
Number of subjects: 78
Study 7041031 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 78
Study 7041031 — intervention group
Group type: EXPERIMENTAL
Intervention: Small cell carcinoma
Number of subjects: 78
Study 7041031 — intervention group
Group type: EXPERIMENTAL
Intervention: Squamous cell carcinoma
Number of subjects: 78
Study 31834660 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate periodontal therapy (one‐stage scaling and root planning, amoxicillin 500 mg, metronidazole 400 mg, oral hygiene instructions)
Number of subjects: 88
Study 31834660 — intervention group
Group type: COMPARATOR
Intervention: Delayed periodontal therapy (control group)
Number of subjects: 88
Study 30835526 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Support training
Number of subjects: 75
Study 29080862 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline metabolite score (weighted sum of 5 metabolites: trimethylamine N-oxide, betaine, choline, phosphocholine, α-glycerophosphocholine)
Number of subjects: 980
Study 29080862 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline metabolite score
Number of subjects: 980
Study 29080862 — intervention group
Group type: COMPARATOR
Intervention: Control group (Mediterranean diet)
Number of subjects: 980
Study 25747518 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV education and information sharing programs
Number of subjects: 26
Study 25747518 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored HPV education programs
Number of subjects: 26
Study 25747518 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel approach to address barriers
Number of subjects: 26
Study 25067790 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month lifestyle intervention consisting of physical fitness training and counseling sessions
Number of subjects: 57
Study 22803615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (45 or 90 mg) with isoniazid (INH) prophylaxis
Number of subjects: 3177
Study 22803615 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3177
Study 19517674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (100 microg)
Number of subjects: 60
Study 19517674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl (25 microg)
Number of subjects: 60
Study 19517674 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (morphine and fentanyl)
Number of subjects: 60
Study 19517674 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 19087079 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral nifedipine tablet
Number of subjects: 90
Study 19087079 — intervention group
Group type: COMPARATOR
Intervention: 250 microgram bolus terbutaline subcutaneously
Number of subjects: 90
Study 15870622 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 12
Study 15870622 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 12
Study 15870622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12496548 — intervention group
Group type: EXPERIMENTAL
Intervention: Stoppa technique
Number of subjects: 39
Study 12496548 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic extraperitoneal repair (TEPP)
Number of subjects: 39
Study 9263935 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 0
Study 9263935 — intervention group
Group type: COMPARATOR
Intervention: Increasing employees' participation and control (organizational intervention)
Number of subjects: 0
Study 8203837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparfloxacin (SPX) 400 mg on day 1 and 200 mg on days 2 to 8
Number of subjects: 12
Study 8203837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparfloxacin (SPX)
Number of subjects: 12
Study 8203837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3300178 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim 300 mg daily
Number of subjects: 24
Study 3300178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11979239 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-volume epinephrine injection (13-20 mL)
Number of subjects: 156
Study 11979239 — intervention group
Group type: COMPARATOR
Intervention: Small-volume epinephrine injection (5-10 mL)
Number of subjects: 156
Study 29888938 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion for thought insertion
Number of subjects: 60
Study 29888938 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion for alien control
Number of subjects: 60
Study 29888938 — intervention group
Group type: COMPARATOR
Intervention: Random responding suggestion
Number of subjects: 60
Study 27112637 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (3mg)
Number of subjects: 17
Study 27112637 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (10mg)
Number of subjects: 17
Study 27112637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 22032553 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) - Health Dialog's Looking Ahead: choices for medical care when you're seriously ill (booklet and DVD)
Number of subjects: 51
Study 22032553 — intervention group
Group type: COMPARATOR
Intervention: Standard Palliative Care (PC) consultation
Number of subjects: 51
Study 21828036 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol (MF/F) 100/10 μg b.i.d.
Number of subjects: 746
Study 21828036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 746
Study 21828036 — intervention group
Group type: COMPARATOR
Intervention: Formoterol (F) 10 μg
Number of subjects: 746
Study 21828036 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate (MF) 100 μg
Number of subjects: 746
Study 20189089 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit feedback plus site-specific interventions (n=6)
Number of subjects: 3311